Form 8-K - Current report:
SEC Accession No. 0001193125-26-338019
Filing Date
2026-08-06
Accepted
2026-08-06 16:11:40
Documents
11
Period of Report
2026-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-20260806.htm   iXBRL 8-K 55790
2 EX-99.1 xene-ex99_1.htm EX-99.1 268118
3 GRAPHIC img189401473_0.jpg GRAPHIC 4758
  Complete submission text file 0001193125-26-338019.txt   464350

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20260806.xsd EX-101.SCH 32035
14 EXTRACTED XBRL INSTANCE DOCUMENT xene-20260806_htm.xml XML 4914
Mailing Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada
Business Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 261249138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)